TruScreen Group Limited

ASX:TRU ISIN:NZTRUE0001S7

TruScreen Group LimitedTruScreen Group Limited (NZE:TRU) (ASX:TRU) is a New Zealand-based medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. Unlike many cervical screening devices, that have only triage/adjunct functionality, the TruScreen device is registered as a primary screening tool.

TruScreen's cervical screening technology effectively resolves many of the ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure.

The device is CE-marked, meaning it meets EU safety, health and environmental protection standards required for sale and use throughout Europe. It is also National Medical Products Administration approved for sale in China.

TruScreen is currently targeting product sales to a range of low and middle-income countries, including China, Mexico, Vietnam, Russia, and Saudi Arabia, where no large-scale cervical cancer screening programs and infrastructure are currently in place. By doing so, the Company hopes to help improve the health and wellbeing of women worldwide.

 
   

News

TruScreen Group Limited (ASX:TRU) (NZE:TRU) Re-Enters India Appointing Medical Products Distributor

🕔5/1/2025 11:08:24 AM

TruScreen Group Limited (ASX:TRU) (NZE:TRU) advises that it has re-entered the Indian subcontinent with the appointment of India medical products distributor Renovate Biologicals Pvt Ltd to distribute its unique AI enabled TruScreen cervical cancer screening system in India.

Read Full Article

TruScreen Group Limited (NZE:TRU) (ASX:TRU) - Key Markets Update

🕔11/13/2024 7:48:10 AM 8393

TruScreen Group Limited (NZE:TRU) (ASX:TRU) is pleased to provide an update of its key markets and target markets.

Read Full Article
###

503 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 14) (Last 30 Days: 50) (Since Published: 503) 

Company Data

    Headquarters
  • Suite 3.03, 18-20 Orion Rd
    Lane Cove NSW 2066
    Australia
  • Telephone
  • +61 (0) 2 8999 3820 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.truscreen.com
  • E:
  • info@truscreen.com

More News Results

  • 2025/05/01: Published Saudi Arabia Study Confirms TruScreen's Results*
  • 2025/04/30: TruScreen Re-enters India Appointing New Distributor*
  • 2025/04/23: Vale Professor Ron Jones*
  • 2025/04/22: TruScreen Launches 260,000 Women Screening Program in HCMC*
  • 2025/04/07: Changes to US and China Tariff Regimes Have No Impact on TRU*
  • 2025/03/24: TruScreen to Present at Singapore Health Day Forum*
  • 2025/03/10: Cleansing Notice*
  • 2025/03/10: Appendix 2A*
  • 2025/03/10: Capital Change Notice*
  • 2025/03/03: Investor Presentation March 2025*
*refer to company website

Social Media